Monoacylglycerolacetyltransferase-2 (MGAT2) is a potential target for the treatment of type II diabetes. We report here the optimisation of a series of MGAT2 inhibitors with regard to their potency and permeability. Improvements in permeability, as measured by increased flux in a Caco-2 assay, were achieved through substitution at the 9-position of the core. We propose that reduction of the NH hydrogen-bond donor strength was primarily responsible for these effects.
单酰
甘油乙酰转移酶-2(MGAT2)是治疗2型糖尿病的潜在靶点。我们在此报告了一系列MGAT2
抑制剂在有效性和通透性方面的优化。通过在核心的9位进行替代,我们在Caco-2测定中观察到通透性改善,表现为流量增加。我们认为NH氢键供体强度的降低是导致这些效果的主要原因。